GSK8573
GSK8573 is an inactive structural analog of the BRD9 inhibitor GSK2801, serving as a negative control compound. It binds to BRD9 with a Kd of 1.04 μM and is used in both in vitro and in vivo studies to validate the on-target effects of bromodomain inhibitors in epigenetics and cancer research.
Product Specifications
CAS Number
1693766-04-9
Product Name Alternative
Control compound, BRD9, biological, BAZ2A, BAZ2B, EpigeneticReaderDomain, Epigenetic Reader Domain, GSK 8573, GSK8573, GSK-8573, Inhibitor, inhibit
Field of Research
Epigenetics & Chromatin
Purity
99.81% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.18 mM) ; DMSO:22 mg/mL (68.03 mM)
Smiles
CCCOc1ccn2c (cc (-c3cccc (OC) c3) c2c1) C (C) =O
Molecular Formula
C20H21NO3
Molecular Weight
323.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1156902 1.0 µg DNA
KLHL9 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details RC229022L4V 200 µL
MCTP2 (NM_001159643) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
